Anthem teams up with insurers to lower prescription drug costs.
- Anthem, one of the biggest U.S. payers, has joined an initiative to create low-cost generic drugs for hospital and retail pharmacies.
- The initiative CivicaScript, a subsidiary of hospital-owned nonprofit drugmaker Civica Rx, plans to initially develop and manufacture six to 10 common, but pricey, generic medicines that don’t have enough market competition to drive down cost, officials said Wednesday.
- The first generics could be available as early as 2022. Civica declined to share specific medications or categories it is pursuing, citing competitive reasons.